US consumer health giant Procter & Gamble's India unit said on Tuesday it had stopped manufacture and sale of its cough-and-cold medicine Vicks Action 500 Extra with immediate effect, after regulators banned it citing potential health risk.
The product is a fixed dose combination of paracetamol, phenylephrine and caffeine, which was banned by the Health Ministry in a notice issued over the weekend, Procter & Gamble Hygiene and Health Care Ltd informed the stock exchange.
P&G stops selling Vicks Action 500 Extra in India with immediate effect - IBNLive
The product is a fixed dose combination of paracetamol, phenylephrine and caffeine, which was banned by the Health Ministry in a notice issued over the weekend, Procter & Gamble Hygiene and Health Care Ltd informed the stock exchange.
P&G stops selling Vicks Action 500 Extra in India with immediate effect - IBNLive
